Han Wen-Yong, Wang Jian-Shu, Zhao Jia, Long Lin, Cui Bao-Dong, Wan Nan-Wei, Chen Yong-Zheng
Generic Drug Research Center of Guizhou Province, Green Pharmaceuticals Engineering Research Center of Guizhou Province, School of Pharmacy , Zunyi Medical University , Zunyi 563000 , China.
J Org Chem. 2018 Jun 15;83(12):6556-6565. doi: 10.1021/acs.joc.8b00866. Epub 2018 Jun 4.
Herein is disclosed a selective and facile approach for the construction of CFH-containing pyrazolo[1,5- c]quinazolines from easily accessible 3-ylideneoxindoles and in situ generated CFHCHN. The reaction involving a [3 + 2] cycloaddition/1,3-H shift/rearrangement/dehydrogenation cascade proceeded smoothly at room temperature in the absence of catalyst and additive. Moreover, this metal-free process along with mild conditions is desirable and valuable for the pharmaceutical industry. Importantly, this reaction features a broad substrate scope, good functional group tolerance, and gram-scale synthesis.
本文公开了一种从易于获得的3-亚烷基氧化吲哚和原位生成的CFHCHN构建含CFH的吡唑并[1,5-c]喹唑啉的选择性且简便的方法。该反应涉及[3 + 2]环加成/1,3-氢迁移/重排/脱氢级联反应,在室温下无催化剂和添加剂的情况下顺利进行。此外,这种无金属过程以及温和的条件对制药行业来说是理想且有价值的。重要的是,该反应具有广泛的底物范围、良好的官能团耐受性以及克级规模的合成。